Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris: A Single Arm, Open-label Exploratory Trial

Next Previous
Trial Profile

Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris: A Single Arm, Open-label Exploratory Trial

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Mar 2018

At a glance

  • Drugs Secukinumab (Primary)
  • Indications Pityriasis rubra pilaris
  • Focus Therapeutic Use

    • Most Recent Events

    • 20 Mar 2018 Planned End Date changed from 30 Nov 2020 to 15 Apr 2020.
    • 20 Mar 2018 Planned primary completion date changed from 30 Nov 2019 to 15 Apr 2019.
    • 20 Mar 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top